Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials.
Saved in:
| Title: | Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials. |
|---|---|
| Authors: | Rogak L; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA., Forschmiedt JK; University of Minnesota School of Public Health: University of Minnesota Twin Cities School of Public Health, USA., Basch E; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Mazza GL; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA., Lee MK; Mayo Clinic, Department of Quantitative Health Sciences, Rochester, MN, USA., Meek EA; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA., Ginos B; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA., Langlais BT; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA., Noble BN; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA., Deal AM; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Yee C; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA., Thanarajasingam G; Mayo Clinic, Division of Hematology, Rochester, MN, USA., Dueck AC; Mayo Clinic, Department of Quantitative Health Sciences, Scottsdale, AZ, USA. |
| Source: | Contemporary clinical trials communications [Contemp Clin Trials Commun] 2025 Sep 02; Vol. 47, pp. 101547. Date of Electronic Publication: 2025 Sep 02 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101671157 Publication Model: eCollection Cited Medium: Internet ISSN: 2451-8654 (Electronic) Linking ISSN: 24518654 NLM ISO Abbreviation: Contemp Clin Trials Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
